hotspot -WSS

hotspot

author：explore 2025-10-01 17:56:40 - browse：869

An import ban of certain Apple Watches officially goes into effect on Tuesday. Justin Sullivan/Getty Images

An import ban of certain Apple Watches officially goes into effect on Tuesday, after the U.S. International Trade Commission deemed the blood oxygen measurement feature too similar to products patented by pulse oximetry company Masimo. It’s the first time Apple has ever faced such a ban.

President Biden had the chance to veto the ban until Christmas day, but he didn’t, as a statement from his trade representative made clear Tuesday morning. Now, Apple has to decide how much it values this feature, and if it’s willing to take a hit on its journey to establish the Apple Watch as a necessary public health tool.

“We strongly disagree with the USITC decision and resulting exclusion order, and are taking all measures to return Apple Watch Series 9 and Apple Watch Ultra 2 to customers in the U.S. as soon as possible,” Apple spokesperson Nikki Rothberg wrote in an email to STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： PBM reform efforts get punted in Congress

WSS

Doctors find melanoma drugs effective against rare brain cancer

The Harvard botanist who searched for psychedelics in the Amazon

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Community Health Systems hospitals under DOJ investigation

Doctors find melanoma drugs effective against rare brain cancer

Group opposing PBM reform sets lobbying record

knowledge

hotspot

leisure time

Activists slam private health insurers over coverage restrictions

Ed Silverman on new gene therapies, biosimilars, coffee, and more

DIEP, the 'gold standard' of breast reconstruction, is under threat

Startup Neumora takes a novel depression drug to Phase 3

How to save PrEP access — and even expand it

Community Health Systems hospitals under DOJ investigation

Heart attack and stroke risk calculators need revising

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

The high cost of giving birth even with insurance

Startup Neumora takes a novel depression drug to Phase 3

hotspot

6 phony surgeries that take placebo to the extreme

Sanofi seeks simpler, safer CRISPR sickle cell cure

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

The Harvard botanist who searched for psychedelics in the Amazon

A new nitrogen execution bill also undermines medical licensing

New documents shed light on MD Anderson Cancer Institute feud

knowledge

entertainment

leisure time

focus